Join
Live feed
·
PRReleasevia Quantisnow
European Biotech Acquisition Corp. logo

Oculis SA and European Biotech Acquisition Corp announce business combination agreement to create Nasdaq-listed biopharmaceutical company driving breakthrough innovations in ophthalmology

ByQuantisnow·Wall Street's wire, on your screen.
EBAC· European Biotech Acquisition Corp.
Finance

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EBAC (European Biotech Acquisition Corp.) and more on Quantisnow.